ZYBERNO
Stock Report
Updated Sep 1, 2026

Catheter Precision, Inc. (VTAK)

Healthcare • NYSE

$0.20

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
20.0/100
POOR BUSINESS
Catheter Precision, Inc. (VTAK) scores 20/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-132.0%)
Debt-to-Equity (Solvency Risk):GOOD (0.31x)
Operating Margin (Operational Efficiency):CRITICAL (-1,000.3%)
Return on Capital (Capital Efficiency):CRITICAL (-75.1%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Catheter Precision, Inc. (VTAK) stock report — Zyberno Score 20/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, VTAK generated -$8.77M in Owner Earnings. Capital was deployed as follows: $13.00K invested in capital expenditures. Reinvestment rate: -490.4%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.20
Market Cap:$548.78K

Valuation Multiples (3)

P/B Ratio:0.03x
P/S Ratio:0.29x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$2.53M

Price Action & Momentum (1)

% of 52-Week High:6.2%
B. Profitability Assessment

Return Metrics (5)

ROA:-45.9%
Reinvestment Rate:-490.4%
Fundamental Growth Rate (g):368.4%

Margin Analysis (3)

Operating Margin Ttm:-1,000.3%
Net Margin Ttm:-679.1%
Ebitda Margin:-824.3%

TTM Performance (3)

Gross Margin Ttm:47.7%
Operating Margin Ttm:-1,000.3%
Net Margin Ttm:-679.1%

Yield Metrics (2)

Earnings Yield:-$9.28K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-3,001.5%
Latest Earnings Filed:2023-03-28

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):100.0%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.19x
Quick Ratio:0.18x
Cash Ratio:0.05x

Leverage Analysis (3)

Debt To Equity Ttm:0.31x
Debt-to-Equity Ratio:0.31x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-125.11x
Times Interest Earned:-125.11

Capital Structure (4)

Working Capital:-10,942,000.00
Cash And Cash Equivalents:643,000.00
Long Term Debt:$1.16M
Net Debt:$1.99M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.92M
Linear Growth: 100.0%
📊 Click to view full VTAK Revenue analysis & methodology →
Cost Of Revenue Ttm:$1.00M

Profitability Breakdown (2)

Gross profit TTM: $914.00K
Linear Growth: 36.3%
📊 Click to view full VTAK Gross Profit analysis & methodology →
-$19.16M

Bottom Line Performance (3)

-$13.01M
Income Before Tax:-$13.81M
Ebitda Ttm:-15,786,000.00

Operating Expenses (5)

Operating Expenses:20,069,000.00
R And D Expense:895,000.00
Sga Expense:12,179,000.00
Income Tax Expense:-$623.00K
Interest Expense:169,000.00

Expense Ratios (3)

R And D To Revenue Percentage:87.8%
Sga To Revenue Percentage:1,195.2%
Ebitda Margin:-824.3%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$36.87M
Current Assets:$2.51M
Ppe Net:128,000.00
Goodwill:0.00
Intangible Assets:$18.60M

Liability Structure (4)

Total Liabilities:19,732,000.00
Current Liabilities:13,452,000.00
Long Term Debt:$1.16M
Short Term Debt:$1.47M

Equity & Capital (3)

Equity:$17.14M
Retained Earnings:-$314.51M
Common Stock:500,000,000.00

Working Capital Items (3)

Accounts Receivable:120,000.00
Inventory:88,000.00
Accounts Payable:1,447,000.00

Special Items (2)

Contract Liabilities:145,000.00
Stock Based Compensation:266,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$8.75M-$8.77M

Investment Activities (2)

Investing Cash Flow:-$1.32M
Capital Expenditures Ttm:13,000.00

Financing Activities (3)

Financing Cash Flow:$4.47M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:37,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:3,369,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-17.47
-$25.98
Earnings Per Share Ttm:-$4.70

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.69
Operating Cash Flow Per Share:-$3.00

Book Value & Capital (2)

Book Value Per Share:$6.19
Cash Per Share:0.23

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.07x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:15.96x
Days Sales Outstanding Ttm:22.87

Inventory Management (2)

Inventory Turnover Ttm:11.38x
Days Inventory Outstanding Ttm:32.09

Payables & Cash Cycle (2)

Days Payable Outstanding:527.63
Cash Conversion Cycle:-472.67
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:60.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$8.77M

Damodaran Growth Analysis (2)

Reinvestment Rate:-490.4%
Fundamental Growth Rate (g):368.4%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):100.0%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):36.3%
Book Value Growth Rate (Linear):-19.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:VTAK
Company Name:Catheter Precision, Inc.
Sector:Healthcare
Industry:Medical Devices
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:2.77M
Shares Outstanding Basic:2.77M
Shares Outstanding Diluted:1.09K

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 20:47:05 UTC
Data Timestamp:2026-08-22T11:29:22.269330
Scroll to Top